Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke

BACKGROUND AND PURPOSE: Intravenous (IV) tissue plasminogen activator (tPA) is the only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA patients are typically monitored in an intensive care unit (ICU) for at least 24 hours. However, rigorous evidence to supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Faigle, Roland, Sharrief, Anjail, Marsh, Elisabeth B., Llinas, Rafael H., Urrutia, Victor C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922971/
https://www.ncbi.nlm.nih.gov/pubmed/24533130
http://dx.doi.org/10.1371/journal.pone.0088652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922971/
https://www.ncbi.nlm.nih.gov/pubmed/24533130
http://dx.doi.org/10.1371/journal.pone.0088652

Ejemplares similares